About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Socs4m1Nch
mutation 1, Sandra E Nicholson
MGI:7587716
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Socs4m1Nch/Socs4m1Nch C.C3Fe-Socs4m1Nch MGI:7593757
hm2
Socs4m1Nch/Socs4m1Nch C3H/He-Socs4m1Nch MGI:7593761
hm3
Socs4m1Nch/Socs4m1Nch C6.C3Fe-Socs4m1Nch MGI:7593763


Genotype
MGI:7593757
hm1
Allelic
Composition
Socs4m1Nch/Socs4m1Nch
Genetic
Background
C.C3Fe-Socs4m1Nch
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Socs4m1Nch mutation (0 available); any Socs4 mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• normal thymocyte development and composition of peripheral immune cells under steady-state conditions
• normal TGFB and IL10 levels in lung after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal cytokine and chemokine production in lung and spleen 3 days after systemic administration of poly I:C
• fewer virus-specific T cells in bronchioalveolar lavage (BAL) sample 5 and 6 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal virus-specific T cell number in BAL sample 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in mediastinal lymph node (MLN) after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• more virus-specific T cells in spleen 5 and 6 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 2 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in spleen 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in mediastinal lymph node (MLN) after i.n. inoculation with 10<3> pfu of influenza strain X31
• higher percentage of CD62L and lower percentage of CD62L CD8<+> T cells in mediastinal lymph node (MLN) 5 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• increased CXCL1, CXCL2 and CCL2 levels in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 5-7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 20 pfu of H1N1 influenza strain A/Puerto Rico/8/34 (PR8)
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)

hematopoietic system
• fewer virus-specific T cells in bronchioalveolar lavage (BAL) sample 5 and 6 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal virus-specific T cell number in BAL sample 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in mediastinal lymph node (MLN) after i.n. inoculation with 10<3> pfu of influenza strain X31
• in lung 3 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• more virus-specific T cells in spleen 5 and 6 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal in lung 2 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in spleen 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31
• normal virus-specific T cell number in mediastinal lymph node (MLN) after i.n. inoculation with 10<3> pfu of influenza strain X31
• higher percentage of CD62L and lower percentage of CD62L CD8<+> T cells in mediastinal lymph node (MLN) 5 days after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)
• normal 7 days after i.n. inoculation with 10<3> pfu of influenza strain X31

growth/size/body
N
• no obvious phenotype

embryo
N
• viable

mortality/aging
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 20 pfu of H1N1 influenza strain A/Puerto Rico/8/34 (PR8)
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)

reproductive system




Genotype
MGI:7593761
hm2
Allelic
Composition
Socs4m1Nch/Socs4m1Nch
Genetic
Background
C3H/He-Socs4m1Nch
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Socs4m1Nch mutation (0 available); any Socs4 mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• normal thymocyte development and composition of peripheral immune cells under steady-state conditions
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)

growth/size/body
N
• no obvious phenotype

embryo
N
• viable

mortality/aging
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)

reproductive system




Genotype
MGI:7593763
hm3
Allelic
Composition
Socs4m1Nch/Socs4m1Nch
Genetic
Background
C6.C3Fe-Socs4m1Nch
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Socs4m1Nch mutation (0 available); any Socs4 mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• normal thymocyte development and composition of peripheral immune cells under steady-state conditions
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)

growth/size/body
• no obvious phenotype

embryo
• viable

mortality/aging
• increased lung viral load, disease progression (weight loss) and mortality after intranasal (i.n.) inoculation with 10<3> pfu of influenza strain H3N2 A/Hong Kong x31 (X31)

reproductive system





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory